Study finds immune markers at two months tied to longer survival in glioblastoma trial
Researchers at The University of Texas MD Anderson Cancer Center have identified blood-based biomarkers that can help distinguish patients with glioblastoma who are most likely to live longer from novel treatment with an ...
8 minutes ago
0
0









